Oaktree Capital Management closed its life sciences lending fund and its related vehicles, with total capital commitments in excess of $2.3 billion. The fund, which is Oaktree’s first dedicated life sciences fund, was oversubscribed.
Oaktree Capital Management closed Oaktree European Capital Solutions Fund III, a private debt fund that closed with a total capital commitment of €1.2 billion ($1.33 billion).
Oaktree Capital Management launched its private credit-focused Oaktree Lending Partners and its related vehicles (OLP). OLP is targeting $10 billion in equity commitments from institutional investors.
Oaktree Specialty Lending closed its previously announced merger with Oaktree Strategic Income Corporation (OCSI), with Oaktree Specialty Lending as the surviving company.
Oaktree Specialty Lending, a specialty finance company, reported financial results for the fiscal quarter ended June 30, 2020, including total investment income of $34.4 million, which was up from $34.2 million for fiscal Q2/20.